A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)
Clinical trial NCT05345236 · COMPLETED
Trial details
- NCT number
- NCT05345236
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2022-01-25
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.